Published in Arch Dermatol on September 01, 2002
How I treat hemophagocytic lymphohistiocytosis. Blood (2011) 5.08
Drug associated vanishing bile duct syndrome combined with hemophagocytic lymphohistiocytosis. World J Gastrointest Endosc (2012) 0.80
The Skin as an Early Expression of Malignancies in the Neonatal Age: A Review of the Literature and a Case Series. Biomed Res Int (2015) 0.79
Familial hemophagocytic lymphohistiocytosis in two Saudi siblings. Sudan J Paediatr (2015) 0.75
Preceding Annular Skin Lesions in a Patient with Hemophagocytic Lymphohistiocytosis. Ann Dermatol (2015) 0.75
Haemophagocytic lymphohistiocytosis with lung cavity and lytic bone lesion in a 45 day infant. J Clin Diagn Res (2014) 0.75
De novo germline and postzygotic mutations in AKT3, PIK3R2 and PIK3CA cause a spectrum of related megalencephaly syndromes. Nat Genet (2012) 4.51
Variable response to propranolol treatment of kaposiform hemangioendothelioma, tufted angioma, and Kasabach-Merritt phenomenon. Pediatr Blood Cancer (2012) 2.29
Prospective study of infantile hemangiomas: clinical characteristics predicting complications and treatment. Pediatrics (2006) 2.28
Long-term hydroxyurea therapy for infants with sickle cell anemia: the HUSOFT extension study. Blood (2005) 1.99
Prospective study of infantile hemangiomas: demographic, prenatal, and perinatal characteristics. J Pediatr (2007) 1.96
Growth characteristics of infantile hemangiomas: implications for management. Pediatrics (2008) 1.95
Stroke With Transfusions Changing to Hydroxyurea (SWiTCH): a phase III randomized clinical trial for treatment of children with sickle cell anemia, stroke, and iron overload. Pediatr Blood Cancer (2011) 1.89
Infantile hemangiomas: current knowledge, future directions. Proceedings of a research workshop on infantile hemangiomas, April 7-9, 2005, Bethesda, Maryland, USA. Pediatr Dermatol (2005) 1.77
Delayed hemolytic transfusion reaction/hyperhemolysis syndrome in children with sickle cell disease. Pediatrics (2003) 1.67
Risk for PHACE syndrome in infants with large facial hemangiomas. Pediatrics (2010) 1.60
Risk of recurrent stroke in children with sickle cell disease receiving blood transfusion therapy for at least five years after initial stroke. J Pediatr (2002) 1.50
Pain and other non-neurological adverse events in children with sickle cell anemia and previous stroke who received hydroxyurea and phlebotomy or chronic transfusions and chelation: results from the SWiTCH clinical trial. Am J Hematol (2013) 1.49
Pulmonary, gonadal, and central nervous system status after bone marrow transplantation for sickle cell disease. Biol Blood Marrow Transplant (2009) 1.46
Validity of the child health questionnaire for use in children with sickle cell disease. J Pediatr Hematol Oncol (2004) 1.46
Linear scleroderma en coup de sabre with associated neurologic abnormalities. Pediatrics (2005) 1.43
Retrospective review of adverse effects from propranolol in infants. JAMA Dermatol (2013) 1.40
The Cyrano nose: refinements in surgical technique and treatment approach to hemangiomas of the nasal tip. Plast Reconstr Surg (2010) 1.39
Hypoglycemia in children taking propranolol for the treatment of infantile hemangioma. Arch Dermatol (2010) 1.38
Variation in hospitalizations and hospital length of stay in children with vaso-occlusive crises in sickle cell disease. Pediatr Blood Cancer (2005) 1.35
Pulmonary thromboembolism associated with Klippel-Trenaunay syndrome. Pediatrics (2005) 1.28
Lichenoid eruptions in children. J Am Acad Dermatol (2004) 1.20
Multicenter prospective study of ulcerated hemangiomas. J Pediatr (2007) 1.15
Congenital dermatofibrosarcoma protuberans: variability in presentation. Arch Dermatol (2003) 1.14
Phrynoderma: a manifestation of vitamin A deficiency?... The rest of the story. Pediatr Dermatol (2005) 1.06
Propranolol for infantile hemangiomas: promise, peril, pathogenesis. Pediatr Dermatol (2009) 1.05
Vesicular eczema after intravenous immunoglobulin therapy for treatment of Stevens-Johnson syndrome. Arch Dermatol (2006) 1.04
PHACE syndrome: current knowledge, future directions. Pediatr Dermatol (2009) 0.98
Genetic endothelial systems biology of sickle stroke risk. Blood (2007) 0.97
Medical management of tumors associated with Kasabach-Merritt phenomenon: an expert survey. J Pediatr Hematol Oncol (2013) 0.97
Skin lesions in the neonate. Pediatr Clin North Am (2004) 0.96
Comparison of infantile hemangiomas in preterm and term infants: a prospective study. Arch Dermatol (2008) 0.95
Serum 25-hydroxyvitamin D concentration does not correlate with atopic dermatitis severity. J Am Acad Dermatol (2013) 0.94
Congenital cardiac, aortic arch, and vascular bed anomalies in PHACE syndrome (from the International PHACE Syndrome Registry). Am J Cardiol (2013) 0.93
Partial splenectomy for hereditary spherocytosis: a multi-institutional review. J Pediatr Surg (2011) 0.92
Patient-controlled analgesia for sickle cell pain crisis in a pediatric emergency department. Pediatr Emerg Care (2004) 0.91
Clinical spectrum and risk of PHACE syndrome in cutaneous and airway hemangiomas. Arch Otolaryngol Head Neck Surg (2011) 0.90
The effect of magnesium on length of stay for pediatric sickle cell pain crisis. Acad Emerg Med (2004) 0.90
Intravenous magnesium for pediatric sickle cell vaso-occlusive crisis: methodological issues of a randomized controlled trial. Pediatr Blood Cancer (2014) 0.90
PHACES syndrome: a review. Int J Pediatr Otorhinolaryngol (2008) 0.88
Asymptomatic inflammatory bowel disease presenting with mucocutaneous findings. Pediatrics (2005) 0.88
PHACES association: a vasculocutaneous syndrome. Pediatr Cardiol (2008) 0.88
Cutaneous manifestations of hyper-IgE syndrome in infants and children. J Pediatr (2002) 0.87
Prospective study of the frequency of hepatic hemangiomas in infants with multiple cutaneous infantile hemangiomas. Pediatr Dermatol (2011) 0.87
Neurodevelopmental abnormalities in children with PHACE syndrome. J Child Neurol (2012) 0.86
Immunosuppressive effects in infants treated with corticosteroids for infantile hemangiomas. Arch Dermatol (2010) 0.85
Constipation as a feature of anogenital lichen sclerosus in children. Pediatrics (2005) 0.85
Familial nonmembranous aplasia cutis of the scalp. Pediatr Dermatol (2005) 0.85
Single-chain antibody fragments derived from a human synthetic phage-display library bind thrombospondin and inhibit sickle cell adhesion. Blood (2003) 0.84
A comparison of disease severity among affected male versus female patients with PHACE syndrome. J Am Acad Dermatol (2007) 0.84
Infantile hemangioma. Pediatr Clin North Am (2010) 0.84
Candidate locus analysis for PHACE syndrome. Am J Med Genet A (2012) 0.83
Clinical outcomes of splenectomy in children: report of the splenectomy in congenital hemolytic anemia registry. Am J Hematol (2014) 0.83
A case of ankyloblepharon, ectodermal dysplasia, and cleft lip/palate syndrome with ectrodactyly: are the p63 syndromes distinct after all? Pediatr Dermatol (2011) 0.83
Histopathologic and immunophenotypic profile of subglottic hemangioma: multicenter study. Int J Pediatr Otorhinolaryngol (2009) 0.83
Characteristics of infantile hemangiomas as clues to pathogenesis: does hypoxia connect the dots? Arch Dermatol (2010) 0.82
Dermatologic manifestations of Crohn disease in children: response to infliximab. J Pediatr Gastroenterol Nutr (2003) 0.82
Two cases for diagnosis: asymmetric childhood scleredema or stiff skin syndrome? Pediatr Dermatol (2003) 0.81
Approach to the patient with an infantile hemangioma. Dermatol Clin (2013) 0.81
Annular lipoatrophy of the ankles. J Am Acad Dermatol (2006) 0.81
Academic attainment findings in children with sickle cell disease. J Sch Health (2013) 0.81
Neonatal violaceous skin lesions: expanding the differential of the "blueberry muffin baby". Adv Dermatol (2005) 0.80
Measuring the severity of infantile hemangiomas: instrument development and reliability. Arch Dermatol (2012) 0.80
Treatment of hemangiomas of infancy. Dermatol Ther (2005) 0.79
Copy number variation analysis in 98 individuals with PHACE syndrome. J Invest Dermatol (2012) 0.79
Intertriginous eruption associated with chemotherapy in pediatric patients. Arch Dermatol (2007) 0.78
Propranolol treatment of infantile hemangiomas: anticipatory guidance for parents and caretakers. Pediatr Dermatol (2013) 0.78
Surgical treatment of infantile hemangioma in a multidisciplinary vascular anomalies clinic. Int J Pediatr Otorhinolaryngol (2011) 0.78
Diffuse neonatal hemangiomatosis: an evidence-based review of case reports in the literature. J Am Acad Dermatol (2012) 0.77
Significant systemic absorption of tacrolimus after topical application in a patient with lamellar ichthyosis. Arch Dermatol (2002) 0.77
What syndrome is this? Setleis syndrome. Pediatr Dermatol (2004) 0.77
Nevus simplex: a reconsideration of nomenclature, sites of involvement, and disease associations. J Am Acad Dermatol (2010) 0.77
Microcystic adnexal carcinoma: the first reported congenital case. Pediatr Dermatol (2011) 0.77
Risk of hepatic hemangiomas in infants with large hemangiomas. Arch Dermatol (2010) 0.76
Propranolol use in PHACE syndrome with cervical and intracranial arterial anomalies: collective experience in 32 infants. Pediatr Dermatol (2012) 0.76
Inverse Gottron's papules: an unusual cutaneous manifestation of juvenile dermatomyositis. Pediatr Dermatol (2011) 0.76
Infantile hemangiomas: an update. Am J Clin Dermatol (2013) 0.76
Concurrent poststreptococcal glomerulonephritis and autoimmune hemolytic anemia. Pediatr Nephrol (2003) 0.75
Severe thrombocytopenia in a child secondary to passive platelet antibody transfer from a plasma transfusion. J Pediatr Hematol Oncol (2013) 0.75
Response to "Propranolol Induced Hypoglycemia" by Amir Horev, MD, Alon Haim, MD, Alex Zvulunov, MD. Pediatr Endocrinol Rev (2015) 0.75
Dramatic shift in the infantile hemangioma treatment paradigm at a single institution. Pediatr Dermatol (2013) 0.75
Twin nevus? Pediatr Dermatol (2005) 0.75
Combined antiretroviral therapy during pregnancy and risk of congenital malformations. JAMA (2004) 0.75
When good is not good enough: the predictive value of cutaneous lesions of the lumbosacral region for occult spinal dysraphism. Arch Dermatol (2004) 0.75
Childhood lichen planus: demographics of a U.S. population. Pediatr Dermatol (2010) 0.75
Cutaneous and disseminated blastomycosis: a pediatric case series. Pediatr Dermatol (2012) 0.75
Necrotic facial papules in an adolescent: C2 deficiency with eventual development of lupus erythematosus. Pediatr Dermatol (2003) 0.75
Clear cell papulosis in Hispanic siblings. Arch Dermatol (2007) 0.75
Pneumocystis carinii pneumonia in infant treated with oral steroids for hemangioma. Arch Dermatol (2007) 0.75
Erosive pustular dermatosis of the scalp after perinatal scalp injury. Pediatr Dermatol (2006) 0.75
Risk of dysphagia and speech and language delay in PHACE syndrome. Pediatr Dermatol (2014) 0.75
Association of hearing loss with PHACE syndrome. Arch Dermatol (2010) 0.75
Large plantar mass in a newborn. Pediatr Dermatol (2006) 0.75